Data gathered: December 21
AI Stock Analysis - Mind Medicine (MindMed) (MNMD)
Analysis generated June 5, 2024. Powered by Chat GPT.
Mind Medicine (MindMed) is a biotechnology firm focused on developing psychedelic-inspired medicines and therapies aimed at addressing mental health conditions such as anxiety, depression, and addiction. The company leverages the growing body of clinical research supporting the efficacy of psychedelics, aspiring to bring these therapies to market through rigorous clinical trials and regulatory processes. MindMed operates in a highly specialized sector, which offers both substantial growth potential and significant risk, contingent on regulatory approval and public acceptance.
Stock Alerts - Mind Medicine (MindMed) (MNMD)
 |
Mind Medicine (MindMed) | December 18 Price is up by 5.4% in the last 24h. |
|
Mind Medicine (MindMed) | December 16 Price is up by 5.5% in the last 24h. |
|
Mind Medicine (MindMed) | December 12 Price is down by -5.3% in the last 24h. |
|
Mind Medicine (MindMed) | December 6 Price is up by 5.5% in the last 24h. |
Alternative Data for Mind Medicine (MindMed)
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 3 | Sign up | Sign up | Sign up |
| Sentiment | 96 | Sign up | Sign up | Sign up |
| Webpage traffic | 19,000 | Sign up | Sign up | Sign up |
| Employee Rating | 92 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | 39 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 2 | Sign up | Sign up | Sign up |
| Facebook Followers | 6,543 | Sign up | Sign up | Sign up |
| Instagram Followers | 19,953 | Sign up | Sign up | Sign up |
| Reddit Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 12 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 24,986 | Sign up | Sign up | Sign up |
| Twitter Followers | 23,842 | Sign up | Sign up | Sign up |
| Twitter Mentions | 11 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 87 | Sign up | Sign up | Sign up |
| Linkedin Employees | N/A | Sign up | Sign up | Sign up |
About Mind Medicine (MindMed)
Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness.
| Price | $7.16 |
| Target Price | Sign up |
| Volume | 1,610,000 |
| Market Cap | $514M |
| Year Range | $5.17 - $10 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Drug Manufacturers |
In the news
-inc-logo-1200x675.jpg?v=20240515130629&w=240&h=240&zc=2){kind=logo} |
Wellington Management Group LLP Purchases 109,152 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)December 20 - ETF Daily News |
|
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives $27.71 Consensus Price Target from BrokeragesDecember 18 - ETF Daily News |
|
XTX Topco Ltd Invests $337,000 in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)December 17 - ETF Daily News |
Mind Medicine MindMed : MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD) Form 8 KDecember 15 - Finnhub |
|
Mind Medicine MindMed : Corporate Presentation December 2024December 15 - Finnhub |
|
|
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Position Increased by Charles Schwab Investment Management Inc.December 15 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 0 | 7.6M | -7.6M | -14M | -25M | 0.000 |
| Q2 '24 | 2.5M | 9.8M | -7.3M | -5.9M | -24M | -0.260 |
| Q1 '24 | 0 | 11M | -12M | -54M | -22M | -1.140 |
| Q4 '23 | 1.3M | 11M | -10M | -24M | -21M | -0.590 |
| Q3 '23 | 670,000 | 9.2M | -8.5M | -18M | -21M | -0.450 |
Insider Transactions View All
| Sullivan Mark filed to sell 177,716 shares at $6. September 25 '24 |
| Karlin Dan filed to sell 344,656 shares at $6. September 25 '24 |
| Liao Carrie filed to sell 99,543 shares at $6. September 25 '24 |
| Barrow Robert filed to sell 545,772 shares at $6. September 25 '24 |
| GRYSKA DAVID W filed to buy 17,351 shares at $6. August 26 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$144.47 0% | 40 |
 |
Eli Lilly and CompanyLLY |
$767.76 0% | 61 |
 |
PfizerPFE |
$26.36 0% | 37 |
 |
AstrazenecaAZN |
$65.35 0% | 54 |
 |
AbbVieABBV |
$175.58 0% | 60 |
Read more about Mind Medicine (MindMed) (MNMD) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Mind Medicine (MindMed)?
The Market Cap of Mind Medicine (MindMed) is $514M.
What is the current stock price of Mind Medicine (MindMed)?
Currently, the price of one share of Mind Medicine (MindMed) stock is $7.16.
How can I analyze the MNMD stock price chart for investment decisions?
The MNMD stock price chart above provides a comprehensive visual representation of Mind Medicine (MindMed)'s stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Mind Medicine (MindMed) shares. Our platform offers an up-to-date MNMD stock price chart, along with technical data analysis and alternative data insights.
Does MNMD offer dividends to its shareholders?
As of our latest update, Mind Medicine (MindMed) (MNMD) does not offer dividends to its shareholders. Investors interested in Mind Medicine (MindMed) should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Mind Medicine (MindMed)?
Some of the similar stocks of Mind Medicine (MindMed) are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.